These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: CD209 promoter -336 A/G (rs4804803) polymorphism is associated with susceptibility to pulmonary tuberculosis in Zahedan, southeast Iran.
    Author: Naderi M, Hashemi M, Taheri M, Pesarakli H, Eskandari-Nasab E, Bahari G.
    Journal: J Microbiol Immunol Infect; 2014 Jun; 47(3):171-5. PubMed ID: 23751770.
    Abstract:
    INTRODUCTION: The association between -336 A/G polymorphism of CD209 and susceptibility to/protection from tuberculosis is inconsistent. AIM: The present study aimed at evaluating the possible association between CD209 rs4804803 (-336 A/G) gene polymorphism and pulmonary tuberculosis (PTB) in a sample of Iranian population. MATERIALS AND METHODS: This case-control study was performed on 156 PTB patients and 154 healthy individuals. Tetra-amplification refractory mutation system-polymerase chain reaction was used to detect the polymorphisms. RESULTS: Our findings revealed that the CD209 rs4804803 increased the risk of PTB in codominant [odds ratio (OR) = 5.16, 95% confidence interval (CI) = 1.60-16.59, p = 0.006, GG vs. AA], dominant (OR = 1.69, 95% CI = 1.07-2.66, p = 0.024, AG + GG vs. AA), and recessive (OR = 4.20, 95% CI = 1.34-13.16, p = 0.014, GG vs. AA + AG) tested inheritance models. Furthermore, the rs4804803 G allele increased the risk of PTB (OR = 1.58, 95% CI = 1.12-2.23, p = 0.011) as compared to the A allele. CONCLUSION: Our data suggest that CD209 rs4804803 polymorphism increased the risk of PTB in a sample of Iranian population.
    [Abstract] [Full Text] [Related] [New Search]